Literature DB >> 21078805

Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery.

Ajay Kumar1, Csaba Juhász, Eishi Asano, Sandeep Sood, Otto Muzik, Harry T Chugani.   

Abstract

UNLABELLED: PET has been used for the presurgical localization of epileptic foci for more than 20 y; still, its clinical role in children with intractable epilepsy remains unclear, largely because of variable analytic approaches and different outcome measures. The purpose of the present study was to evaluate and optimize the performance (lateralization and lobar localization value of epileptic foci) of objective voxel-based analysis of (18)F-FDG PET scans in a pediatric epilepsy population.
METHODS: Twenty children with intractable focal epilepsy (mean age ± SD, 11 ± 4 y; age range, 6-18 y) who underwent interictal (18)F-FDG PET, followed by 2-stage epilepsy surgery with chronic subdural electrocorticographic monitoring, and were seizure-free after surgery were included in this study. PET images were analyzed using both a visual-analysis and a statistical parametric mapping (SPM) method. Lateralization value and performance of lobar localization (in lateral and medial surfaces of all lobes, total of 8 regions in each epileptic hemisphere), calculated for 3 different statistical thresholds, were determined against intracranial electrocorticography-determined seizure-onset region and surgical resection site.
RESULTS: SPM using a statistical threshold of P less than 0.001 provided 100% correct lateralization, which was better than visual assessment (90%). Although visual and SPM analyses (with both P < 0.001 and P < 0.0001 thresholds) performed similarly well (with a sensitivity and specificity of 74% or above) in the localization of seizure-onset regions, SPM detected 7 of 9 seizure-onset regions, mostly in medial cortices, that were missed by visual assessment. Also, SPM performed equally well in both hemispheres, compared with visual analysis, which performed better in the left hemisphere. No statistical difference in performance was observed between visual and SPM analyses of children with abnormal versus normal MRI findings or of children with gliosis versus developmental pathology. Clinical variables, such as age, duration of epilepsy, age of seizure onset, and time between PET and last seizure, showed no correlation with sensitivity or specificity of either visual analysis or SPM analysis.
CONCLUSION: SPM analysis, using a young adult control group, can be used as a complementary objective analytic method in identifying epileptogenic lobar regions by (18)F-FDG PET in children older than 6 y.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078805      PMCID: PMC3157889          DOI: 10.2967/jnumed.110.075390

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Seizure outcome after epilepsy surgery in patients with normal preoperative MRI.

Authors:  K Chapman; E Wyllie; I Najm; P Ruggieri; W Bingaman; J Lüders; P Kotagal; D Lachhwani; D Dinner; H O Lüders
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Secondary bilateral synchrony due to fronto-mesial lesions. An invasive recording study.

Authors:  A Cukiert; C Forster; J A Buratini; V B Ferreira; G Gronich
Journal:  Arq Neuropsiquiatr       Date:  1999-09       Impact factor: 1.420

3.  Pediatric intractable epilepsy: the role of presurgical evaluation and seizure outcome.

Authors:  S K Kim; K C Wang; Y S Hwang; K J Kim; I O Kim; D S Lee; Y Yi; B K Cho
Journal:  Childs Nerv Syst       Date:  2000-05       Impact factor: 1.475

4.  Multimodality imaging for focus localization in pediatric pharmacoresistant epilepsy.

Authors:  M Kurian; L Spinelli; J Delavelle; J P Willi; M Velazquez; V Chaves; W Habre; K Meagher-Villemure; E Roulet; J G Villeneuve; M Seeck
Journal:  Epileptic Disord       Date:  2007-02-15       Impact factor: 1.819

5.  Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy.

Authors:  Sang Kun Lee; Seo Young Lee; Kwang-Ki Kim; Kkeun-Sik Hong; Dong-Soo Lee; Chun-Kee Chung
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

6.  Role of subdural electrocorticography in prediction of long-term seizure outcome in epilepsy surgery.

Authors:  Eishi Asano; Csaba Juhász; Aashit Shah; Sandeep Sood; Harry T Chugani
Journal:  Brain       Date:  2009-03-13       Impact factor: 13.501

Review 7.  Neuronuclear assessment of patients with epilepsy.

Authors:  Karolien Goffin; Stefanie Dedeurwaerdere; Koen Van Laere; Wim Van Paesschen
Journal:  Semin Nucl Med       Date:  2008-07       Impact factor: 4.446

8.  The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis.

Authors:  O Willmann; R Wennberg; T May; F G Woermann; B Pohlmann-Eden
Journal:  Seizure       Date:  2007-05-25       Impact factor: 3.184

9.  Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities.

Authors:  Jung Ju Lee; Sang Kun Lee; Seo-Young Lee; Kyung-Il Park; Dong Wook Kim; Dong Soo Lee; Chun Kee Chung; Hyeon Woo Nam
Journal:  Seizure       Date:  2008-03-10       Impact factor: 3.184

Review 10.  The current status of neuroimaging for epilepsy.

Authors:  John Duncan
Journal:  Curr Opin Neurol       Date:  2009-04       Impact factor: 5.710

View more
  32 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Long-term outcome in children with intractable epilepsy showing bilateral diffuse cortical glucose hypometabolism pattern on positron emission tomography.

Authors:  Varun Shandal; Amy L Veenstra; Michael Behen; Senthil Sundaram; Harry Chugani
Journal:  J Child Neurol       Date:  2011-09-22       Impact factor: 1.987

3.  Impact of expectation-maximization reconstruction iterations on the diagnosis of temporal lobe epilepsy with PET.

Authors:  John M Floberg; Aaron F Struck; Brooke K Peters; Christine J Jaskowiak; Scott B Perlman; Lance T Hall
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

4.  Objective PET study of glucose metabolism asymmetries in children with epilepsy: Implications for normal brain development.

Authors:  Vinod K Pilli; Jeong-Won Jeong; Praneetha Konka; Ajay Kumar; Harry T Chugani; Csaba Juhász
Journal:  Hum Brain Mapp       Date:  2018-08-23       Impact factor: 5.038

5.  A pilot study in epilepsy patients using simultaneous PET/MR.

Authors:  Yu-Shin Ding; Bang-Bin Chen; Christopher Glielmi; Kent Friedman; Orrin Devinsky
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

6.  Metabolic correlates of cognitive function in children with unilateral Sturge-Weber syndrome: Evidence for regional functional reorganization and crowding.

Authors:  Jeong-A Kim; Jeong-Won Jeong; Michael E Behen; Vinod K Pilli; Aimee Luat; Harry T Chugani; Csaba Juhász
Journal:  Hum Brain Mapp       Date:  2017-12-23       Impact factor: 5.038

Review 7.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

8.  Corpus Callosotomy for Intractable Epilepsy Revisited: The Children's Hospital of Michigan Series.

Authors:  Aimee F Luat; Eishi Asano; Ajay Kumar; Harry T Chugani; Sandeep Sood
Journal:  J Child Neurol       Date:  2017-03-08       Impact factor: 1.987

Review 9.  Pre-operative evaluation in pediatric patients with cortical dysplasia.

Authors:  Elia M Pestana Knight; Jorge Gonzalez-Martinez; Ajay Gupta
Journal:  Childs Nerv Syst       Date:  2015-08-18       Impact factor: 1.475

10.  Noninvasive predictors of subdural grid seizure localization in children with nonlesional focal epilepsy.

Authors:  Giridhar P Kalamangalam; Elia M Pestana Knight; Shyam Visweswaran; Ajay Gupta
Journal:  J Clin Neurophysiol       Date:  2013-02       Impact factor: 2.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.